The Long Noncoding RNA LnRPT Puts the Brakes on Pulmonary Artery Smooth Muscle Cell Proliferation.
作者信息
Oldham William M
机构信息
1 Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts.
出版信息
Am J Respir Cell Mol Biol. 2018 Feb;58(2):138-139. doi: 10.1165/rcmb.2017-0342ED.
Abstract
摘要
相似文献
1
The Long Noncoding RNA LnRPT Puts the Brakes on Pulmonary Artery Smooth Muscle Cell Proliferation.
Am J Respir Cell Mol Biol. 2018 Feb;58(2):138-139. doi: 10.1165/rcmb.2017-0342ED.
2
The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells.
Am J Respir Cell Mol Biol. 2018 Feb;58(2):181-193. doi: 10.1165/rcmb.2017-0111OC.
3
Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
Exp Biol Med (Maywood). 2017 Mar;242(5):487-496. doi: 10.1177/1535370216685434. Epub 2017 Jan 5.
4
Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?
Am J Respir Cell Mol Biol. 2002 Feb;26(2):171-4. doi: 10.1165/ajrcmb.26.2.f230.
5
[Effect of spleen tyrosine kinase on the proliferation of pulmonary vascular smooth muscle cells in rats].
Zhongguo Dang Dai Er Ke Za Zhi. 2010 Nov;12(11):886-90.
6
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
Circ Res. 2004 Oct 15;95(8):830-40. doi: 10.1161/01.RES.0000145360.16770.9f. Epub 2004 Sep 16.
7
Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21.
Biochem Biophys Res Commun. 2018 Jan 15;495(3):2125-2132. doi: 10.1016/j.bbrc.2017.11.185. Epub 2017 Dec 2.
8
[Progress in research of molecular mechanisms of pulmonary arterial smooth muscle cell proliferation].
Nan Fang Yi Ke Da Xue Xue Bao. 2013 Dec;33(12):1852-5.
9
Peroxynitrite stimulates pulmonary artery endothelial and smooth muscle cell proliferation: involvement of ERK and PKC.
Pulm Pharmacol Ther. 2011 Feb;24(1):100-9. doi: 10.1016/j.pupt.2010.09.003. Epub 2010 Sep 17.
10
Long non-coding RNAs: The growth controller of vascular smooth muscle cells in cardiovascular diseases.
Int J Biochem Cell Biol. 2023 Apr;157:106392. doi: 10.1016/j.biocel.2023.106392. Epub 2023 Feb 23.
引用本文的文献
1
Adipose-derived stem cell exosomes alleviate TGF-β1-induced urethral stricture fibrosis by suppressing the TGF-β/Smad pathway and downstream PDGFR-β/RAS/ERK signaling.
J Cell Commun Signal. 2025 Jun 12;19(2):e70025. doi: 10.1002/ccs3.70025. eCollection 2025 Jun.
2
Roles of LncRNAs in the Pathogenesis of Pulmonary Hypertension.
Rev Cardiovasc Med. 2024 Jun 17;25(6):217. doi: 10.31083/j.rcm2506217. eCollection 2024 Jun.
3
The protective role of EP300 in monocrotaline-induced pulmonary hypertension.
Front Cardiovasc Med. 2023 Feb 22;10:1037217. doi: 10.3389/fcvm.2023.1037217. eCollection 2023.
4
Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
Cells. 2021 Jul 26;10(8):1892. doi: 10.3390/cells10081892.
5
Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.
Int J Mol Sci. 2020 Dec 3;21(23):9222. doi: 10.3390/ijms21239222.
6
Long noncoding RNAs: emerging roles in pulmonary hypertension.
Heart Fail Rev. 2020 Sep;25(5):795-815. doi: 10.1007/s10741-019-09866-2.
本文引用的文献
1
The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells.
Am J Respir Cell Mol Biol. 2018 Feb;58(2):181-193. doi: 10.1165/rcmb.2017-0111OC.
2
Gene regulation of mammalian long non-coding RNA.
Mol Genet Genomics. 2018 Feb;293(1):1-15. doi: 10.1007/s00438-017-1370-9. Epub 2017 Sep 11.
3
Epidemiology and treatment of pulmonary arterial hypertension.
Nat Rev Cardiol. 2017 Oct;14(10):603-614. doi: 10.1038/nrcardio.2017.84. Epub 2017 Jun 8.
4
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.
Hum Mutat. 2015 Dec;36(12):1113-27. doi: 10.1002/humu.22904. Epub 2015 Oct 12.
5
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.
Circ Res. 2014 Jun 20;115(1):165-75. doi: 10.1161/CIRCRESAHA.113.301141.
6
Molecular mechanisms of pulmonary arterial remodeling.
Mol Med. 2014 Apr 22;20(1):191-201. doi: 10.2119/molmed.2013.00165.
7
The metabolic basis of pulmonary arterial hypertension.
Cell Metab. 2014 Apr 1;19(4):558-73. doi: 10.1016/j.cmet.2014.01.004. Epub 2014 Feb 6.
8
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Circulation. 2013 Mar 12;127(10):1128-38. doi: 10.1161/CIRCULATIONAHA.112.000765. Epub 2013 Feb 12.
9
Pulmonary hypertension.
JAMA. 2012 Oct 3;308(13):1366-74. doi: 10.1001/jama.2012.12347.
10
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Chest. 2012 Aug;142(2):448-456. doi: 10.1378/chest.11-1460.
Zotero 插件